Personal profile
Education
- 2012 Ph.D., Pharmacology Institute, National Taiwan University
- 2003 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2025- Director, School of Pharmacy, Taipei Medical University
- 2023- Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2023- Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2023- Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2023- Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2023- Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2023- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2021-2023 Associate Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2021-2023 Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2020-2023 Associate Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2019-2023 Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2018-2023 Associate Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2015-2023 Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014-2018 Assistant Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University
- 2013-2014 postdoc., Taipei Medical University
- 2012-2013 postdoc., National Taiwan University
Awards
- 2013 Outstanding Research Award for Scholar-in-Training, National Taiwan University
Research Interests
- Cancer Biology, Mechanism study of anticancer drugs
Related Link
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Investigating the Antitumor and Immunomodulatory Mechanisms of Steroidal Saponins in Bladder Cancer.
Chen, M.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
海洋生物海綿萃取物對於膀胱癌細胞之抗癌機轉探討
Chen, M.-C. (PI)
7/1/25 → 2/28/26
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanisms of Terpenoids from Marine Sponge in Bladder Cancer
Chen, M.-C. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
華蟾素對於多形性膠質母細胞瘤細胞上 皮間質轉化之影響及抗癌機轉探討
Chen, M.-C. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanisms of Terpenoids from Marine Sponge in Bladder Cancer
Chen, M.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of Enantiomeric Monoterpene-Coumarins with Neuroprotective Activities from the Rhizomes of Luvunga scandens
Bui Nguyen, B. T., Shen, Y. C., Liaw, C. C., Chao, C. H., Tran Huynh, Q. D., Tran, D. H., Vo, T. H., Vo, Q. T., Nguyen, H. H., Lo, I. W., Huang, H. C., Chen, M. C. & Lin, Y. C., Jan 23 2026, In: Journal of Natural Products. 89, 1, p. 281-293 13 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
NMR-Guided Discovery of Luvunga D: A Novel Propellane-Type Limonoid from Luvunga scandens That Functions as a Non-Classical Ferroptosis Inhibitor
Bui Nguyen, B. T., Bui, H. M., Liaw, C. C., Huynh, Q. D. T., Chao, C. H., Tran, D. H., Lo, I. W., Vo, T. H., Koeberle, A., Koeberle, S. C., Chen, M. C. & Lin, Y. C., Mar 2026, In: Antioxidants. 15, 3, 402.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Personalized serum proteome profiles of COVID-19-associated acute respiratory distress syndrome in response to mesenchymal stem cell therapy
Putri, D. U., Chen, M. C., Weng, C. M., Kuo, H. P., Lee, C. H. & Han, C. L., Feb 2026, In: Journal of Microbiology, Immunology and Infection. 59, 1, p. 35-44 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells
Hsieh, T. H., Kuo, H. P., Chen, M. C., Lin, Y. C., Lin, B. J., Hsu, K. C. & Chen, C. H., Dec 2025, In: Scientific Reports. 15, 1, 20922.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Correction to: The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells (Cell Death & Disease, (2013), 4, 9, (e810), 10.1038/cddis.2013.330)
Chen, M. C., Chen, C. H., Wang, J. C., Tsai, A. C., Liou, J. P., Pan, S. L. & Teng, C. M., Jul 2024, In: Cell Death and Disease. 15, 7, 490.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Datasets
-
Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms
Lai, M.-J. (Creator), Lee, C.-H. (Creator), Chao, Y.-H. (Creator), Mehndiratta, S. (Creator), Chen, M.-C. (Creator), Liou, J.-P. (Creator) & Lee, H.-Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13207104.v1, https://tandf.figshare.com/articles/journal_contribution/Effect_of_3-subsitution_of_quinolinehydroxamic_acids_on_selectivity_of_histone_deacetylase_isoforms/13207104/1
Dataset